Search Results - therapeutic

4 Results Sort By:
New Drugs for Treatment of Type 1 Diabetes
Technology Description Oregon State University is seeking a licensee to develop and commercialize a new family of compounds that target the Ah receptor for treatment of Type 1 Diabetes. The compounds are based on the parental compound 11-Cl-BBQ, the use of which is described PCT patent application No. US2015/057873, in U.S. patent No. 10,308,649, and...
Published: 6/23/2020   |   Inventor(s): Jit Chakravarty, Nancy Kerkvliet, Siva Kolluri, Sebastian Bernales
Keywords(s): Diabetes, pharmaceuticals, Therapeutic, Type 1 Diabetes
Category(s): Therapeutics
Peptide Inhibitors of Gonorrhoeae
Technology Description Antigonococcal peptide inhibitors of Neisseria gonorrhoeae that act against a non-conventional new target, nitrite reductase AniA, that is necessary for N. gonorrhoeae anaerobic respiration and biofilm formation. The anaerobic life style is an important state during disease and favored in biofilms, which form in cervical gonococcal...
Published: 6/8/2017   |   Inventor(s): Aleksandra Sikora, Konstantin Korotkov
Keywords(s): Antibiotics, Antimicrobial, Drug, Drug Development, Gonorrhea, Inhibitor, Microbiology, Peptide, Therapeutic
Category(s): Therapeutics, Vaccines
New Approach for Treatment of Type I Diabetes
Technology Description This licensing and collaborative research opportunity relates to a new approach to treating diabetes mellitus type 1 (T1DM). The patent pending methods of treatment focus on the use of compounds that provide suppression of autoimmune responses that lead to destruction of pancreatic beta cells. The possibility of preventing disease...
Published: 5/13/2016   |   Inventor(s): Nancy Kerkvliet, Siva Kolluri
Keywords(s): Diabetes, Drug, Immune, Therapeutic
Category(s): Chemical, Therapeutics
Lymphatic drug delivery system and drugs for metastatic melanoma
Technology Description Oregon State University is seeking a licensee for a patented drug delivery system for the treatment of metastatic melanoma. The system is composed of biodegradable, biocompatible, and stable nanoparticles built from amphiphilic block copolymers and contains a mix of drugs commonly used to treat cancer, all while being nontoxic...
Published: 11/23/2015   |   Inventor(s): Adam Alani
Keywords(s): Cancer, Drug, Drug Delivery, drugs, lymphatic, melanoma, metastatic tumor, Pharmaceuticals, Therapeutic
Category(s): Therapeutics
© 2020. All Rights Reserved. Powered by Inteum